ClinicalTrials.Veeva

Menu

Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy

U

University of Sao Paulo

Status

Completed

Conditions

Prediabetes
Gastric Cancer
Diabetes Mellitus
Morbid Obesity
Colorectal Cancer

Treatments

Other: Interview, questionnaire, updated biochemical tests

Study type

Observational

Funder types

Other

Identifiers

NCT01518023
Lessdiabetes

Details and patient eligibility

About

There is evidence that gastrointestinal operations for non weight-losing purposes are beneficial for diabetes mellitus. Aiming to analyze such hypothesis, patients submitted to gastric bypass for morbid obesity, gastrectomy for gastric cancer and colectomy for colo-rectal cancer will be compared. The end point will be changes in fasting blood glucose and hemoglobin A1c concentration.

Full description

In a prospective protocol with retrospective information, patients (N=240) undergoing bariatric Roux-en-Y gastric bypass (n=80), cancer subtotal or total gastrectomy (n=80) and right colectomy or rectosigmoidectomy (n=80) with follow-up >3 years free of disease, with or without previously impaired fasting blood glucose, will be recruited. Patients will be submitted to a questionnaire involving diet, diagnosis of diabetes and glucose-lowering drugs, body weight and other clinical items. Preoperative information available in the hospital system will be completed and current findings will be updated, including body mass index and biochemical measurements. Using the outcomes of the bariatric population as benchmark, both concerning diabetics that were ameliorated and nondiabetics that progressed to new-onset diabetes,results in the other groups will be compared. The study should answer whether gastric and colorectal surgery for cancer 1) Are beneficial for established diabetes; 2) Attenuate the conversion of normal patients to diabetes, both within a follow-up period of 3- 12 years;

Enrollment

240 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Follow-up period > 3 years,
  • weight stable in the last year

Exclusion criteria

  • Reoperation or take-down of original operation,
  • consumptive diseases,
  • protein-calorie malnutrition,
  • organ failures,
  • pancreatic surgery,
  • cell or organ transplantation,
  • type 1 diabetes,
  • cognitive impairment or Alzheimer disease,
  • refusal to participate in the protocol

Trial design

240 participants in 3 patient groups

Cancer gastrectomy
Description:
Patients previously submitted to partial/total gastrectomy for gastric cancer
Treatment:
Other: Interview, questionnaire, updated biochemical tests
Colorectal cancer operation
Description:
Patients previously submitted to right colectomy or rectosignoidectomy for cancer
Treatment:
Other: Interview, questionnaire, updated biochemical tests
Bariatric patients
Description:
Morbidly obese participants who underwent antiobesity Roux-en-Y gastric bypass
Treatment:
Other: Interview, questionnaire, updated biochemical tests

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems